{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:00:38Z","timestamp":1791889238661,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T00:00:00Z","timestamp":1647648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ebiom.2022.103979","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T23:55:11Z","timestamp":1648770911000},"page":"103979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Potential risks of treating bacterial infections with a combination of \u03b2-lactam and aminoglycoside antibiotics: A systematic quantification of antibiotic interactions in E. coli blood stream infection isolates"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5081-0138","authenticated-orcid":false,"given":"Nikos","family":"Fatsis-Kavalopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lex","family":"Roelofs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6640-2174","authenticated-orcid":false,"given":"Dan I.","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2022.103979_bib0001","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/14787210.2020.1705155","article-title":"Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction","volume":"18","author":"Coates","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ebiom.2022.103979_bib0002","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with gram-negative bacteria","volume":"25","author":"Tamma","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ebiom.2022.103979_bib0003","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1473-3099(10)70139-0","article-title":"Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis","volume":"10","author":"Caminero","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2022.103979_bib0004","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-018-0141-x","article-title":"Drug combinations: a strategy to extend the life of antibiotics in the 21st century","volume":"17","author":"Tyers","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ebiom.2022.103979_bib0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tibtech.2012.12.006","article-title":"Combination approaches to combat multidrug-resistant bacteria","volume":"31","author":"Worthington","year":"2013","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.ebiom.2022.103979_bib0006","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/AAC.01365-09","article-title":"Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis","volume":"54","author":"Micek","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ebiom.2022.103979_bib0007","doi-asserted-by":"crossref","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ebiom.2022.103979_bib0008","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/jhm.899","article-title":"Resistance to empiric antimicrobial treatment predicts outcome in severe sepsis associated with gram-negative bacteremia","volume":"6","author":"Micek","year":"2011","journal-title":"J Hosp Med"},{"key":"10.1016\/j.ebiom.2022.103979_bib0009","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.resmic.2011.11.002","article-title":"Antibiotic and antimicrobial peptide combinations: synergistic inhibition of Pseudomonas fluorescens and antibiotic-resistant variants","volume":"163","author":"Naghmouchi","year":"2012","journal-title":"Res Microbiol"},{"key":"10.1016\/j.ebiom.2022.103979_bib0010","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1592\/phco.2005.25.10.1353","article-title":"Nosocomial infections due to multidrug-resistant pseudomonas aeruginosa: epidemiology and treatment options","volume":"25","author":"Obritsch","year":"2005","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"10.1016\/j.ebiom.2022.103979_bib0011","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00228-010-0794-5","article-title":"Synergy of fosfomycin with other antibiotics for gram-positive and gram-negative bacteria","volume":"66","author":"Kastoris","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ebiom.2022.103979_bib0012","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/1471-2334-14-489","article-title":"Treatment of bloodstream infections in ICUs","volume":"14","author":"Timsit","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ebiom.2022.103979_bib0013","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.copbio.2018.01.026","article-title":"Toward prediction and control of antibiotic-resistance evolution","volume":"54","author":"Furusawa","year":"2018","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.ebiom.2022.103979_bib0014","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1146\/annurev-micro-090816-093813","article-title":"Evolutionary trajectories to antibiotic resistance","volume":"71","author":"Hughes","year":"2017","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.ebiom.2022.103979_bib0015","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1586\/eri.12.50","article-title":"Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes","volume":"10","author":"Martin","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ebiom.2022.103979_bib0016","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00134-001-1143-z","article-title":"Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study","volume":"28","author":"Alberti","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ebiom.2022.103979_bib0017","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012","volume":"39","author":"Dellinger","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ebiom.2022.103979_bib0018","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/1469-0691.12028","article-title":"The changing epidemiology of bacteraemias in Europe: trends from the European antimicrobial resistance surveillance system","volume":"19","author":"de Kraker","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ebiom.2022.103979_bib0019","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1086\/313710","article-title":"Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998","volume":"30","author":"Fluit","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2022.103979_bib0020","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10096-007-0304-6","article-title":"Epidemiology and outcome of primary community-acquired bacteremia in adult patients","volume":"26","author":"Ortega","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ebiom.2022.103979_bib0021","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/cid\/ciaa210","article-title":"Epidemiology of escherichia coli bacteremia: a systematic literature review","volume":"72","author":"Bonten","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2022.103979_bib0022","doi-asserted-by":"crossref","DOI":"10.5812\/jjm.20309v2","article-title":"Antibiotic susceptibility pattern of aerobic and anaerobic bacteria isolated from surgical site infection of hospitalized patients","volume":"8","author":"Akhi","year":"2015","journal-title":"Jundishapur J Microbiol"},{"key":"10.1016\/j.ebiom.2022.103979_bib0023","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12879-015-1050-5","article-title":"Surgical site infection in critically ill patients with secondary and tertiary peritonitis: epidemiology, microbiology and influence in outcomes","volume":"15","author":"Ballus","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ebiom.2022.103979_bib0024","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000000968","article-title":"Treatment of highly virulent extraintestinal pathogenic escherichia coli pneumonia with bacteriophages*","volume":"43","author":"Dufour","year":"2015","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ebiom.2022.103979_bib0025","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s00134-012-2699-5","article-title":"Pathophysiology of Escherichia coli ventilator-associated pneumonia: implication of highly virulent extraintestinal pathogenic strains","volume":"38","author":"Messika","year":"2012","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ebiom.2022.103979_bib0026","doi-asserted-by":"crossref","first-page":"R62","DOI":"10.1186\/cc6890","article-title":"Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized controlled multicenter study","volume":"12","author":"Nseir","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.ebiom.2022.103979_bib0027","doi-asserted-by":"crossref","DOI":"10.1097\/QCO.0b013e32835635cb","article-title":"Changing bacteriology of abdominal and surgical sepsis","volume":"25","author":"Chen","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ebiom.2022.103979_bib0028","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13054-018-2050-9","article-title":"Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia","volume":"22","author":"Thomas-R\u00fcddel","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.ebiom.2022.103979_bib0029","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0891-5520(05)70373-1","article-title":"Diagnosis and treatment of uncomplicated urinary tract infection","volume":"11","author":"Hooton","year":"1997","journal-title":"Infect Dis Clin N Am"},{"key":"10.1016\/j.ebiom.2022.103979_bib0030","first-page":"945","article-title":"Antimicrobial resistance pattern in Escherichia coli causing urinary tract infection among inpatients","volume":"139","author":"Niranjan","year":"2014","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.ebiom.2022.103979_bib0031","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fcimb.2017.00241","article-title":"Metabolic adaptations of uropathogenic E. coli in the urinary tract","volume":"7","author":"Mann","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ebiom.2022.103979_bib0032","series-title":"Tidig Identifiering och Behandling av Sepsis","author":"Reichard","year":"2018"},{"key":"10.1016\/j.ebiom.2022.103979_bib0033","unstructured":"Tecken p\u00e5 allvarlig infektion hos vuxna. 2018; published online Jan 30. http:\/\/strama.se\/wp-content\/uploads\/2018\/03\/Tecken-p%C3%A5-allvarlig-infektion-hos-vuxna-F%C3%A4rdigt-dok.pdf."},{"key":"10.1016\/j.ebiom.2022.103979_bib0034","doi-asserted-by":"crossref","unstructured":"Hanberger H, Edlund C, Furebring M, et al. Rational use of aminoglycosides-review and recommendations by the Swedish Reference Group for Antibiotics (SRGA). null 2013;45:161\u201375.","DOI":"10.3109\/00365548.2012.747694"},{"key":"10.1016\/j.ebiom.2022.103979_bib0035","series-title":"E. Coli Infections-Importance of Early Diagnosis and Efficient Treatment","article-title":"Management of E. coli sepsis","author":"Kumar","year":"2020"},{"key":"10.1016\/j.ebiom.2022.103979_bib0036","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with gram-negative bacteria","volume":"25","author":"Tamma","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ebiom.2022.103979_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000856","article-title":"CombiANT: antibiotic interaction testing made easy","volume":"18","author":"Fatsis-Kavalopoulos","year":"2020","journal-title":"PLoS Biol"},{"key":"10.1016\/j.ebiom.2022.103979_bib0038","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0031-6997(25)00026-2","article-title":"What is synergy?","volume":"41","author":"Berenbaum","year":"1989","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ebiom.2022.103979_bib0039","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/AAC.48.3.693-715.2004","article-title":"Combination antifungal therapy","volume":"48","author":"Johnson","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ebiom.2022.103979_bib0040","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1128\/AAC.00497-10","article-title":"Synergy testing by etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant acinetobacter baumannii","volume":"54","author":"Sopirala","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ebiom.2022.103979_bib0041","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1128\/AAC.40.8.1914","article-title":"Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test","volume":"40","author":"White","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ebiom.2022.103979_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ebiom.2022.103979_bib0043","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1017\/S002217240001158X","article-title":"The estimation of the bactericidal power of the blood","volume":"38","author":"Miles","year":"1938","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ebiom.2022.103979_bib0044","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0031-6997(25)06847-4","article-title":"The search for synergy: a critical review from a response surface perspective","volume":"47","author":"Greco","year":"1995","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ebiom.2022.103979_bib0045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF02289447","article-title":"A rationale and test for the number of factors in factor analysis","volume":"30","author":"Horn","year":"1965","journal-title":"Psychometrika"},{"key":"10.1016\/j.ebiom.2022.103979_bib0046","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/03009734.2014.899279","article-title":"Combination antibiotic therapy for multidrug-resistant gram-negative bacteria","volume":"119","author":"T\u00e4ngd\u00e9n","year":"2014","journal-title":"Ups J Med Sci"},{"key":"10.1016\/j.ebiom.2022.103979_bib0047","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1473-3099(18)30673-X","article-title":"Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study","volume":"19","author":"Z\u00fcrcher","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2022.103979_bib0048","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/clinids\/13.4.550","article-title":"Bacteremia caused by enterobacter: 15 years of experience in a cancer hospital","volume":"13","author":"Bodey","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ebiom.2022.103979_bib0049","first-page":"96","article-title":"Antibiotic synergism and response in gram-negative bacteremia in granulocytopenic cancer patients","volume":"80","author":"De Jongh","year":"1986","journal-title":"Am J Med"},{"key":"10.1016\/j.ebiom.2022.103979_bib0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jac\/19.3.321","article-title":"Comparison of the activity of antibiotic combinations in vitro with clinical outcome and resistance emergence in serious infection by Pseudomonas aeruginosa in non-neutropenic patients","volume":"19","author":"Chandrasekar","year":"1987","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ebiom.2022.103979_bib0051","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0002-9343(89)80611-4","article-title":"Antibiotic therapy for pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients","volume":"87","author":"Hilf","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.ebiom.2022.103979_bib0052","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003344.pub3","article-title":"Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis","author":"Paul","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ebiom.2022.103979_bib0053","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jac\/dkm193","article-title":"Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials","volume":"60","author":"Vidal","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ebiom.2022.103979_bib0054","unstructured":"Bliziotis IA, Samonis G, Vardakas KZ, Chrysanthopoulou S, Falagas ME. Effect of Aminoglycoside and b-lactam combination therapy versus b-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, Controlled Trials. 10."},{"key":"10.1016\/j.ebiom.2022.103979_bib0055","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1128\/AAC.00115-10","article-title":"Influence of empiric therapy with a \u03b2-lactam alone or combined with an aminoglycoside on prognosis of bacteremia due to gram-negative microorganisms","volume":"54","author":"Mart\u00ednez","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ebiom.2022.103979_bib0056","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archinte.1991.00400050040010","article-title":"Mechanisms of bacterial resistance to antibiotics","volume":"151","author":"Dever","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ebiom.2022.103979_bib0057","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.cbpa.2003.08.004","article-title":"Mechanisms of resistance to antibiotics","volume":"7","author":"Wright","year":"2003","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.ebiom.2022.103979_bib0058","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4103\/joacp.JOACP_349_15","article-title":"Action and resistance mechanisms of antibiotics: a guide for clinicians","volume":"33","author":"Kapoor","year":"2017","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"10.1016\/j.ebiom.2022.103979_bib0059","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/femsre\/fuaa001","article-title":"Antibiotic resistance: turning evolutionary principles into clinical reality","volume":"44","author":"Andersson","year":"2020","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.ebiom.2022.103979_bib0060","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nchembio.559","article-title":"Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy","volume":"7","author":"Ejim","year":"2011","journal-title":"Nat Chem Biol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422001633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422001633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:18:44Z","timestamp":1762456724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422001633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":60,"alternative-id":["S2352396422001633"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.103979","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential risks of treating bacterial infections with a combination of \u03b2-lactam and aminoglycoside antibiotics: A systematic quantification of antibiotic interactions in E. coli blood stream infection isolates","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.103979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103979"}}